WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H596014
CAS#: 916484-16-7
Description: J-30 is a bioactive chemical.
Hodoodo Cat#: H596014
Name: J-30
CAS#: 916484-16-7
Chemical Formula: C21H19N3O4S
Exact Mass: 409.11
Molecular Weight: 409.460
Elemental Analysis: C, 61.60; H, 4.68; N, 10.26; O, 15.63; S, 7.83
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: J-30; J30; J 30; UNII-0896Z9T2XN;
IUPAC/Chemical Name: N-(1-((4-methoxyphenyl)sulfonyl)indolin-7-yl)isonicotinamide
InChi Key: QGWOKAXBIMWTNE-UHFFFAOYSA-N
InChi Code: InChI=1S/C21H19N3O4S/c1-28-17-5-7-18(8-6-17)29(26,27)24-14-11-15-3-2-4-19(20(15)24)23-21(25)16-9-12-22-13-10-16/h2-10,12-13H,11,14H2,1H3,(H,23,25)
SMILES Code: O=C(NC1=CC=CC2=C1N(S(=O)(C3=CC=C(OC)C=C3)=O)CC2)C4=CC=NC=C4
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 409.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Singh SK, Pandey H, Al-Bassam J, Gheber L. Bidirectional motility of kinesin-5
motor proteins: structural determinants, cumulative functions and physiological
roles. Cell Mol Life Sci. 2018 May;75(10):1757-1771. doi:
10.1007/s00018-018-2754-7. Epub 2018 Feb 3. Review. PubMed PMID: 29397398.
2: Hawkins SA, Gillett J. Reconstructing Aboriginal Identity and the Meaning of
the Body in Blood Donation Decisions. J Relig Health. 2015 Aug;54(4):1286-301.
doi: 10.1007/s10943-014-9879-2. Review. PubMed PMID: 24833161.
3: Agis-Balboa RC, Fischer A. Generating new neurons to circumvent your fears:
the role of IGF signaling. Cell Mol Life Sci. 2014 Jan;71(1):21-42. doi:
10.1007/s00018-013-1316-2. Epub 2013 Mar 30. Review. PubMed PMID: 23543251.
4: Tang YC, Thoman M, Linton PJ, Deisseroth A. Use of CD40L immunoconjugates to
overcome the defective immune response to vaccines for infections and cancer in
the aged. Cancer Immunol Immunother. 2009 Dec;58(12):1949-57. doi:
10.1007/s00262-009-0718-3. Epub 2009 May 15. Review. PubMed PMID: 19444444.
